Chess with bacteria

  07 July 2020

Both infection and cancer are evolutionary diseases where any therapy that falls short of a complete cure exerts evolutionary pressure, driving development of resistance mechanisms. We begin to understand that, like in a game of chess, treating such conditions requires not only a good first move (i.e. administering the right drug), but also anticipating the reaction this and all subsequent interventions might provoke. To facilitate such strategies, the recent study by Lukačišinová and colleagues tracked the evolution of bacteria in response to antibiotics and identified genes that, when lost, diminish the extent of resistance and/or the rate at which it is developed.

Further reading: Nature Research
Author(s): Marcin Józef Suskiewicz
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed